- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04281368
Analysis of All Stillbirths in Stockholm County 2017, a Multidisciplinary Audit
April 9, 2020 updated by: Eva Wiberg-Itzel, Karolinska Institutet
All stillbirths in Stockholm during 2017 were analysed according to the primary outcomes which were preventable/non-preventable deaths and the level of delay.
The secondary outcomes were: causes of death, standard of care pre and post stillbirth and if a summary of the possible causes of death was made as well as the planning of supervision of the next pregnancy.
Study Overview
Detailed Description
This is a retrospective cohort study.
A multidisciplinary team consisting of three obstetricians, one midwife and one neonatologist was assembled.
The team represented the largest hospitals in the region-Karolinska University Hospital and Stockholm Soderl Hospital.
Each team member in the audit group had access to all the medical patient charts from the hospitals and also the majority of the charts from the antenatal care clinics (ANC).
Each team member independently assessed each case regarding causes of death, preventable/non-preventable deaths, the level of delay if there was any and the standard of healthcare provided to the patients with stillbirth, the postmortem examination of infant and mother and if there were any recommendations given for the next pregnancy.
Multiple meetings were organized for discussing the results of the individual assessment of each case.
To enable an ethical discussion every member of the audit group signed a confidentiality form and all cases were assessed by comparison with local guidelines in praxis.
Study Type
Observational
Enrollment (Actual)
79
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 18239
- Eva Wiberg-Itzel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
All stillbirths in Stockholm 2017
Description
Inclusion Criteria:
- All stillbirths in Stockholm 2017
Exclusion Criteria:
- Missed abortion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The rate of preventable/non-preventable deaths and the level of delay
Time Frame: 2017
|
to analyze preventable/non-preventable deaths and the level of delay
|
2017
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The frequency of different causes of death
Time Frame: 2017
|
To analyze the different causes of death
|
2017
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eva Wiberg-Itzel, PhD, KI
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
January 1, 2020
Study Registration Dates
First Submitted
February 20, 2020
First Submitted That Met QC Criteria
February 20, 2020
First Posted (Actual)
February 24, 2020
Study Record Updates
Last Update Posted (Actual)
April 13, 2020
Last Update Submitted That Met QC Criteria
April 9, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IUFD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intra-Uterine Death
-
University Hospital, RouenTerminatedSpontaneous Intra Uterine Fetal DeathFrance
-
Assiut UniversityCompletedIntra Uterine Fetal Death
-
HaEmek Medical Center, IsraelTerminatedIntra-uterine ResiduaIsrael
-
Beni-Suef UniversityNot yet recruitingIntra-uterine Device ComplicationEgypt
-
Ain Shams UniversityCompletedIntra-uterine Device ComplicationEgypt
-
University Hospital, GhentImelda Hospital, BonheidenNot yet recruitingIntra-uterine Device Placement
-
Nantes University HospitalTerminated
-
Showa UniversityCompletedIntra-uterine Device ComplicationIndonesia
-
University Hospital, GhentTerminatedCaesarean Section | Learning Curve | Intra-uterine DeviceBelgium
Clinical Trials on Analysis of IUFD
-
Centre Hospitalier Universitaire DijonRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
University of ParmaITI International Team for Implantology, SwitzerlandCompletedInflammation | Periodontitis | Peri-ImplantitisItaly
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Cancer Research UKUnknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
IRCCS Policlinico S. DonatoRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruitingSpinal DeformityBelgium
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada